OpenLegislation

Division 2.3.1

United Kingdom

Original text. Later amendments are not shown.

Avermectins

Pharmacologically active substance(s)Marker residueAnimal speciesMRLsTarget tissuesOther provisions
MoxidectinMoxidectinEquidae50 μg/kgMuscleProvisional MRLs expire on 1 January 2000
500 μg/kgFat
100 μg/kgLiver
50 μg/kgKidney